At a glance
ClinicalIndex Comparison RecordN/ACompleted· 105 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis Korean Patients: a Multicenter Post-marketing Observational Study
In Brief
An observational study for Colitis, Ulcerative. Completed, enrolled 105 participants across 15 sites.
Detailed Summary
The purpose of this study is to assess the clinical effectiveness by the clinical response at 6 weeks and the safety of vedolizumab intravenous in UC Korean participants.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsColitis, Ulcerative
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartAug 2017
First PostedMay 2018
Primary CompletionDec 2018
TodayJul 2026
First PostedMay 24, 2018
Enrollment StartAug 17, 2017
Primary CompletionDec 18, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.1 years ago